Clearside Biomedical, Inc.
CLSD
$3.70
-$0.39-9.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.50M | -8.22M | -7.31M | -7.69M | -7.59M |
| Total Depreciation and Amortization | 84.00K | 85.00K | 79.00K | 75.00K | 44.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.74M | 3.19M | 1.63M | 3.08M | 1.43M |
| Change in Net Operating Assets | -2.05M | -879.00K | 346.00K | -1.38M | 437.00K |
| Cash from Operations | -4.73M | -5.83M | -5.25M | -5.91M | -5.68M |
| Capital Expenditure | 0.00 | -9.00K | -444.00K | -53.00K | -423.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 9.75M | 1.60M | -11.01M |
| Cash from Investing | 0.00 | -9.00K | 9.31M | 1.55M | -11.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 977.00K | 447.00K | 2.08M | 14.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -500.00K | -1.00M | -- | -- | -- |
| Cash from Financing | 477.00K | -553.00K | 2.08M | 14.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.25M | -6.39M | 6.13M | -4.35M | -17.12M |